Stocks · Health care · Pharmaceutical Preparations

Keros Therapeutics, Inc.

KROS Clue Score73
United States Fiscal year ends December CIK 0001664710 Results filed 5 Nov 2026

What the insiders did Net selling

Insider
Date
Role
Action
Shares
Price
Amount
Jean Jacques Bienaime
17 Aug 2026
Director
Buy
1,000
$10.27
$10.27K
Jean Jacques Bienaime
15 Jul 2026
Director
Buy
1,000
$10.61
$10.61K
Jean Jacques Bienaime
15 Jun 2026
Director
Buy
1,000
$10.19
$10.19K
Jean Jacques Bienaime
15 May 2026
Director
Buy
1,000
$10.58
$10.58K
Jean Jacques Bienaime
15 Apr 2026
Director
Buy
1,000
$11.70
$11.70K
Jean Jacques Bienaime
9 Mar 2026
Director
Buy
2,000
$11.21
$22.42K

What was left out

Form 4 filings counted 34
Amendments (4/A) skipped 1
Filings about a different issuer 0
Unreadable filings 0
Joint filings 1
Sales on a Rule 10b5-1 plan 5
Sales straight out of an exercise 0
Sales at will 7
Transactions with no price 0
Shares from compensation/vesting 868,776
History held since 8 Apr 2020